drugset / Trial / NCT03370562

Dexmedetomidine After Cesarean for the Treatment of Nausea and Shivering

NCT03370562 ↗

Completed 100 enrolled Beth Israel Deaconess Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized double blinded trial to determine if a small dose of dexmedetomidine can prevent and relieve nausea and shivering, two of the more common complaints after cesarean delivery.

Timeline

Start
2020-02-18
Primary completion
2020-03-20
Completion
2020-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 10 ug Intravenous

Indications

No indication recorded.